ADMA Biologics, Inc. (ADMA)
9.545
-0.30
(-3.00%)
USD |
NASDAQ |
Aug 24, 16:00
9.545
0.00 (0.00%)
After-Hours: 20:00
ADMA Biologics Shareholders Equity (Quarterly) : 408.21M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 408.21M |
| March 31, 2026 | 390.32M |
| December 31, 2025 | 477.32M |
| September 30, 2025 | 431.19M |
| June 30, 2025 | 398.32M |
| March 31, 2025 | 373.42M |
| December 31, 2024 | 349.02M |
| September 30, 2024 | 231.89M |
| June 30, 2024 | 188.27M |
| March 31, 2024 | 153.71M |
| December 31, 2023 | 135.21M |
| September 30, 2023 | 151.44M |
| June 30, 2023 | 146.76M |
| March 31, 2023 | 145.65M |
| December 31, 2022 | 151.97M |
| September 30, 2022 | 100.38M |
| June 30, 2022 | 114.40M |
| March 31, 2022 | 126.93M |
| December 31, 2021 | 141.17M |
| September 30, 2021 | 102.78M |
| June 30, 2021 | 111.59M |
| March 31, 2021 | 112.50M |
| December 31, 2020 | 88.25M |
| September 30, 2020 | 71.38M |
| June 30, 2020 | 76.88M |
| Date | Value |
|---|---|
| March 31, 2020 | 96.34M |
| December 31, 2019 | 26.19M |
| September 30, 2019 | 36.12M |
| June 30, 2019 | 46.91M |
| March 31, 2019 | 10.04M |
| December 31, 2018 | 19.77M |
| September 30, 2018 | 37.21M |
| June 30, 2018 | 51.76M |
| March 31, 2018 | 23.03M |
| December 31, 2017 | 40.33M |
| September 30, 2017 | 12.99M |
| June 30, 2017 | 27.68M |
| March 31, 2017 | -10.76M |
| December 31, 2016 | -4.457M |
| September 30, 2016 | -0.1521M |
| June 30, 2016 | 3.916M |
| March 31, 2016 | -3.369M |
| December 31, 2015 | 0.821M |
| September 30, 2015 | 4.914M |
| June 30, 2015 | 9.520M |
| March 31, 2015 | 13.43M |
| December 31, 2014 | 6.009M |
| September 30, 2014 | 9.245M |
| June 30, 2014 | 12.30M |
| March 31, 2014 | 15.90M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Erasca, Inc. | 361.87M |
| Krystal Biotech, Inc. | 1.359B |
| Vericel Corp. | 370.04M |
| Emergent BioSolutions, Inc. | 341.40M |
| Exelixis, Inc. | 1.844B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 684.21M |
| Total Liabilities (Quarterly) | 276.00M |
| Debt to Equity Ratio | 0.4994 |
| Current Ratio | 6.972 |
| Net Debt Paydown Yield | -1.29% |